Huang Jun-Qian, Wang Fang, Wang Long-Tao, Li Yong-Mei, Lu Jun-Li, Chen Jian-You
Department of Respiratory and Critical Medicine, Qingdao Chengyang District People's Hospital, Qingdao, Shandong, People's Republic of China.
Department of Respiratory Medicine, Qingdao Municipal Hospital, Qingdao, Shandong, People's Republic of China.
J Asthma Allergy. 2021 Sep 29;14:1197-1207. doi: 10.2147/JAA.S326058. eCollection 2021.
Asthma belongs to chronic inflammatory respiratory diseases characterized by airway inflammation and remodeling. Circular RNAs (circRNAs) are promising therapeutic targets for various diseases, including asthma. In this work, we aim to investigate the role of circular RNA Erb-B2 receptor tyrosine kinase 2 (circERBB2) during progression of asthma.
Human airway smooth muscle cells (ASMCs) were treated with platelet-derived growth factor BB (PDGF-BB) to mimic cell remodeling. The expression of , and insulin-like growth factor 1 receptor was measured by qRT-PCR. Cell proliferation, migration and apoptosis were determined by cell counting-8 (CCK-8), transwell, and flow cytometry. Protein levels of PCNA, MMP-9, IGF1R were evaluated using Western blotting. The levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 were detected by enzyme-linked immunosorbent assay (ELISA). Luciferase reporter gene experiment was adopted to evaluate the targeting relationship between with and . Interaction between RNAs was determined by RNA pulldown and RIP assay.
The depletion of attenuated the proliferation, migration, and levels of inflammatory factors induced by PDGF-BB and cell apoptosis. was identified to directly interact with p, and overexpression of abolished the function of on PDGF-BB-stimulated ASMCs. was identified as a target of , and knockdown of relieved the PDGF-BB-induced ASMCs proliferation and migration.
Our work disclosed that knockdown of circERBB2 suppressed PDGF-BB-caused proliferation, migration and inflammatory response of ASMCs, through regulating miR-98-5p/IGF1R signaling, presented circERBB2 as a promising therapeutic target for asthma.
哮喘属于以气道炎症和重塑为特征的慢性炎症性呼吸道疾病。环状RNA(circRNAs)是包括哮喘在内的各种疾病有前景的治疗靶点。在本研究中,我们旨在探讨环状RNA表皮生长因子受体2(circERBB2)在哮喘进展过程中的作用。
用人血小板衍生生长因子BB(PDGF-BB)处理人气道平滑肌细胞(ASMCs)以模拟细胞重塑。通过qRT-PCR检测 、 和胰岛素样生长因子1受体的表达。通过细胞计数-8(CCK-8)、Transwell和流式细胞术测定细胞增殖、迁移和凋亡。使用蛋白质印迹法评估增殖细胞核抗原(PCNA)、基质金属蛋白酶-9(MMP-9)、胰岛素样生长因子1受体(IGF1R)的蛋白水平。通过酶联免疫吸附测定(ELISA)检测肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)和白细胞介素-6的水平。采用荧光素酶报告基因实验评估 与 和 之间的靶向关系。通过RNA下拉和RNA免疫沉淀实验(RIP)确定RNA之间的相互作用。
的缺失减弱了PDGF-BB诱导的细胞增殖、迁移、炎症因子水平及细胞凋亡。 被鉴定为直接与p相互作用, 的过表达消除了 对PDGF-BB刺激的ASMCs的作用。 被鉴定为 的一个靶点, 敲低减轻了PDGF-BB诱导的ASMCs增殖和迁移。
我们的研究表明,敲低circERBB2通过调节miR-98-5p/IGF1R信号通路抑制PDGF-BB引起的ASMCs增殖、迁移和炎症反应,提示circERBB2是哮喘有前景的治疗靶点。